alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED FINANCIAL STATEMENTS OF INCOME AND CONSOLIDATED BALANCE
SHEETS AND IS QUALIFIED BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-END>                               JUN-28-1997
<CASH>                                           19819
<SECURITIES>                                      2852
<RECEIVABLES>                                    46233
<ALLOWANCES>                                      3832
<INVENTORY>                                      84859
<CURRENT-ASSETS>                                162050
<PP&E>                                            9378
<DEPRECIATION>                                    5703
<TOTAL-ASSETS>                                  170189
<CURRENT-LIABILITIES>                           111001
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             6
<OTHER-SE>                                       59188
<TOTAL-LIABILITY-AND-EQUITY>                    170189
<SALES>                                          82080
<TOTAL-REVENUES>                                 82080
<CGS>                                            72378
<TOTAL-COSTS>                                    72378
<OTHER-EXPENSES>                                  7815
<LOSS-PROVISION>                                    86
<INTEREST-EXPENSE>                                 353
<INCOME-PRETAX>                                   2240
<INCOME-TAX>                                       825
<INCOME-CONTINUING>                               1415
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      1415
<EPS-PRIMARY>                                      .25
<EPS-DILUTED>                                      .25
        

</TABLE>
<TABLE> <S> <C>



<ARTICLE>                                           7
<MULTIPLIER>                                   1,000,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   DEC-31-1999
<DEBT-HELD-FOR-SALE>                           17,268
<DEBT-CARRYING-VALUE>                          0
<DEBT-MARKET-VALUE>                            0
<EQUITIES>                                     3,104
<MORTGAGE>                                     0
<REAL-ESTATE>                                  0
<TOTAL-INVEST>                                 21,539
<CASH>                                         359
<RECOVER-REINSURE>                             6,029
<DEFERRED-ACQUISITION>                         1,418
<TOTAL-ASSETS>                                 37,561
<POLICY-LOSSES>                                22,528
<UNEARNED-PREMIUMS>                            2,534
<POLICY-OTHER>                                 0
<POLICY-HOLDER-FUNDS>                          1,874
<NOTES-PAYABLE>                                956
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    150
<COMMON>                                       5
<OTHER-SE>                                     5,420
<TOTAL-LIABILITY-AND-EQUITY>                   37,561
<PREMIUMS>                                     6,896
<INVESTMENT-INCOME>                            1,151
<INVESTMENT-GAINS>                             699
<OTHER-INCOME>                                 285
<BENEFITS>                                     5,385
<UNDERWRITING-AMORTIZATION>                    1,839
<UNDERWRITING-OTHER>                           731
<INCOME-PRETAX>                                988
<INCOME-TAX>                                   268
<INCOME-CONTINUING>                            720
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   720
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0
<RESERVE-OPEN>                                 12,495
<PROVISION-CURRENT>                            4,162
<PROVISION-PRIOR>                              233
<PAYMENTS-CURRENT>                             1,228
<PAYMENTS-PRIOR>                               2,867
<RESERVE-CLOSE>                                13,210
<CUMULATIVE-DEFICIENCY>                        238



</TABLE>
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.2480 Quality control kit for culture media. ( a ) *Identification.* A quality control kit for culture media is a device that consists of paper discs (or other suitable materials), each impregnated with a specified, freeze-dried, viable microorganism, intended for medical purposes to determine if a given culture medium is able to support the growth of that microorganism. The device aids in the diagnosis of disease caused by pathogenic microorganisms and also provides epidemiological information on these diseases.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 54 FR 25046, June 12, 1989; 66 FR 38791, July 25, 2001]
kPINPOINT 40

Luna Ditch Diversion Project

Pine Lawn

(State)

Head of

the Ditch

Smith

Cr.

Jackson Cr.

Romero Cr.

Noland Cr.

S A Cr.

Jenkins Cr.

æäAP

4225

¬«435

¬«12

Apache County

Catron County

Apache County

Greenlee County

Catron County

Green el e County

49Þ¿

Þ¿4000M

Þ¿545

Þ¿306

Þ¿35

Þ¿209

2Þ¿

36Þ¿

20

çå141

çå385

æäB

080

æäB

024

æäB

012

æäB

007

æäB

002

æäB

003

æäB

026

æäB

025

æäB

083

æäB

013

æäB

009

æäB

089

æäB

029

Lower San

Francisco

Plaza

Luna

Reserve

San

Francisco

Plaza

(/180

(/180

Noland

Mountain

7339

White

Bluff

7241

Maverick

Peak

7881

Dillon

Mountain

8694

Turner

Peak

9429

Maness

Mountain

8094

Mess Box

Mesa

7743

Black Bull

Peak

8369

Black

Peak

9006

San Francisco

Mountains

8465

Jones

Peak

9022

Hell Roaring

Mesa

8514

Freeman

Mountain

8773

Maness

Peak

8258

Higgins

Mountain

6486

Bishop

Peak

8855

Prairie

Point Peak

8333

Negrohead

Butte

7887

Maness

Mountain

7995

Monument

Mountain

8333

Horse

Mesa

8438

Jim Smith

Peak

9252

Joe Green

Peak

7897

Bill Lewis

Mesa

7260

Hellroaring

Mesa

7858

Bill Lee

Mesa

8219

Bar N L

Mesa

8136

Red Butte

8123

Turner

Peak

9170

Leggett

Peak

7930

Bar NL

Mesa

7644

§¦180

2

æäAP

2310

æäGR

67004

124

63

1261

769

62

9

351

33

36

762

515

125

21

34

35

119

761

126

109

64

956

61

çå275

Dry BlueCr.

San

Francisco R.

San

Francisco R.

Centerfire

Cr.

Blue R.

San

Francisco R.

Canovas Cr.

Coyote

Cr.

Dillman Cr.

Pac

C

e

r.

Dry

Blue

Cr.

Stone Cr.

Tularosa

R.

Trou

Cr

t

.

LUNA RESTORATION PROJECT: FIGURE 6

0 1 2 4

Miles

Created On: 5/13/2016 3:55:28 PM

Coordinate System: NAD 1983 UTM Zone 12NTransverse Mercator

o 1 in = 2 miles

1:125,000

(printed on 11" x 17" portrait layout)

Created By: jjelacic

The USDA is an equal opportunity provider, employer, and lender

Figure 6: Location of streams and

riparian areas associated with

proposed restoration activities.

This figure does not include the

locations of proposed sediment

control structures or areas of

seeding in the Spur Draw

watershed.

Luna Planning Area

Luna (185,586 ac.)

! City/Town

Highway

Improved Road, Paved

Improved Road, Gravel

Improved Road, Dirt

Unimproved Road

Non-motorized Trail

Motorized Trail

H Transmission Line

County Boundary

US Forest Service

Bureau of Land Mgmt.

Private

State

Stream and Riparian Restoration

Streams

Perrenial Streams

Project Streams
EX-10.4



 EXHIBIT 10.4 

BELMONT SAVINGS BANK 

SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN 

APPENDIX A-4 

Except as otherwise defined in this Appendix, the terms used herein shall have the meaning(s) ascribed to them in the Belmont Savings Bank
Supplemental Executive Retirement Plan (“Plan”), to which this Appendix, as amended from time to time, is appended and into which this Appendix is incorporated by reference. 

Participant’s Benefit Percentage: 20% of Participant’s Final Average Compensation (as defined in the Plan), multiplied by the
Participant’s Vested Percentage, as set forth herein: 
  

							
	Participant Name	  	Date of Hire	  	Years of Service	  	Vested Percentage
	 Carroll M. Lowenstein, Jr.
	  	September 15, 2010	  	5-9	  	50%
		  		  	10 or more	  	100%

 Notwithstanding the foregoing, if prior to the completion of ten (10) Years of Service, the Participant either is
terminated by the Bank without Cause or resigns for Good Reason, the Participant’s “Benefit Percentage” shall be multiplied by the following: 
  

			
	Years of Service	  	Vested Percentage
	5	  	60%
	6	  	70%
	7	  	80%
	8	  	90%
	9	  	100%


  
 A-4
#### Lewis Weldon *v.*Mildred M. Weldon

King, C. J., Alcorn, House, Thim and Ryan, Js.

Argued December 3

decided December 17, 1968

*600
      *James N. Egan,*for the appellant (plaintiff).

*Norris L. O’Neill,*for the appellee (defendant).

Per Curiam.

The judgment is affirmed since the subordinate facts found support the referee’s conclusions and no error of law appears.

There is no error.
IN THE SUPREME COURT OF PENNSYLVANIA 

MIDDLE DISTRICT 

COMMONWEALTH OF PENNSYLVANIA, 

 Respondent 

 v. 

JOEL G. MUIR, 

 Petitioner 

:

:

:

:

:

:

:

:

:

:

:

No. 912 MAL 2015 

Petition for Allowance of Appeal from 

the Order of the Superior Court 

ORDER 

PER CURIAM 

AND NOW, this 8th day of March, 2016, the Petition for Allowance of Appeal is 

DENIED. 

Justice Eakin did not participate in the decision of this matter. 

Justice Donohue did not participate in the consideration or decision of this 

matter.
IB 

Union Calendar No. 167 

118TH CONGRESS 

1ST SESSION H. R. 764 

[Report No. 118–206] 

To require the Secretary of the Interior to reissue regulations removing 

the gray wolf from the list of endangered and threatened wildlife under 

the Endangered Species Act of 1973. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 2, 2023 

Mrs. BOEBERT (for herself, Mr. TIFFANY, Mr. BERGMAN, Mr. BIGGS, Mr. 

GALLAGHER, Mr. LAMALFA, Mr. MOYLAN, Mr. NEHLS, Mr. NEWHOUSE, 

Mr. OGLES, Mr. PERRY, Mr. ROSENDALE, Mr. STAUBER, Mr. ZINKE, Mr. 

GROTHMAN, Mr. GOSAR, Mr. CRANE, Mr. VAN ORDEN, Mr. STEIL, Mr. 

FITZGERALD, Mrs. FISCHBACH, Mr. BUCK, and Mr. MOOLENAAR) introduced the following bill; which was referred to the Committee on Natural 

Resources 

SEPTEMBER 20, 2023 

Additional sponsors: Ms. HAGEMAN, Mr. BENTZ, and Mr. FULCHER

SEPTEMBER 20, 2023 

Reported from the Committee on Natural Resources; committed to the Committee of the Whole House on the State of the Union and ordered to be 

printed 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 764 RH

A BILL 

To require the Secretary of the Interior to reissue regulations 

removing the gray wolf from the list of endangered and 

threatened wildlife under the Endangered Species Act 

of 1973. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 764 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Trust the Science 

5 Act’’. 

6 SEC. 2. REMOVING THE GRAY WOLF FROM THE LIST OF EN7 DANGERED AND THREATENED WILDLIFE. 

8 Not later than 60 days after the date of enactment 

9 of this section, the Secretary of the Interior shall reissue 

10 the final rule entitled ‘‘Endangered and Threatened Wild11 life and Plants; Removing the Gray Wolf (Canis lupus) 

12 From the List of Endangered and Threatened Wildlife’’ 

13 and published on November 3, 2020 (85 Fed. Reg. 

14 69778). 

15 SEC. 3. NO JUDICIAL REVIEW. 

16 Reissuance of the final rule under section 2 shall not 

17 be subject to judicial review. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Union Calendar No. 167 

118TH CONGRESS 

1ST SESSION H. R. 764 

[Report No. 118–206] 

A BILL 

To require the Secretary of the Interior to reissue 

Endangered Species Act of 1973. of endangered and threatened wildlife under the regulations removing the gray wolf from the list 

SEPTEMBER 20, 2023 

Committed to the Committee of the Whole House on the 

State of the Union and ordered to be printed 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.3124 Phthalocyanine green. ( a ) *Identity.* The color additive is phthalocyanine green (CAS Reg. No. 1328-53-6), Colour Index No. 74260.
( b ) *Uses and restrictions.* ( 1 ) The substance listed in paragraph (a) of this section may be used as a color additive in contact lenses in amounts not to exceed the minimum reasonably required to accomplish the intended coloring effect.
( 2 ) Authorization for this use shall not be construed as waiving any of the requirements of sections 510(k), 515, and 520(g) of the Federal Food, Drug, and Cosmetic Act with respect to the contact lens in which the additive is used.
( c ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( d ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore the color additive is exempt from the certification requirements of section 721(c) of the act.
[51 FR 11433, Apr. 3, 1986]
EXHIBIT  10.57.3

                 THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT


This  is  to  confirm  that  effective  October  16, 2000, that certain Loan and
Security  Agreement  dated  June  18,  1999,  between CELTIC CAPITAL CORPORATION
(Secured  Party)  and  National  Manufacturing  Technologies, Inc., a California
corporation  (Debtor)  is  hereby  amended  to  read  as  follows:

1.11     "A/R  MAXIMUM  COMMITMENT" -  at any time of determination, the amount,
if  any,  by  which  $3,500,000.00 exceeds the aggregate principal amount of any
advances  or  other extensions of credit outstanding from Lender to or on behalf
of  any  of  the  Affiliates  other  than  Borrower for the purpose of financing
accounts  receivable.

1.32     "INVENTORY MAXIMUM COMMITMENT" - at any time of determination, the
amount,  if  any,  by  which $650,000.00 exceeds the aggregate principal amount
of  any advances  or   other  extensions  of  credit outstanding  from  Lender
to  or  on  behalf  of  any of the Affiliates other  than  Borrower  for  the
purpose  of  financing  inventory.


In all other respects, the Loan and Security Agreement, as amended, shall remain
in  full  force  and  effect.



NATIONAL  MANUFACTURING  TECHNOLOGIES,  INC.          CELTIC CAPITAL CORPORATION
Debtor                                                Secured  Party

/s/  Patrick  W.  Moore                              /s/  Alexander  Falo
-----------------------                              --------------------
By:  Patrick  W.  Moore                              By:  Alexander  Falo
Its:  PRESIDENT                                    Its:  VICE  PRESIDENT-CREDIT
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.4465 Gas-powered jet injector. ( a ) *Identification.* A gas-powered jet injector is a syringe device intended to administer a local anesthetic. The syringe is powered by a cartridge containing pressurized carbon dioxide which provides the pressure to force the anesthetic out of the syringe.
( b ) *Classification.* Class II.
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.5530 Immunoglobulin G (Fc fragment specific) immunological test system. ( a ) *Identification.* An immunoglobulin G (Fc fragment specific) immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the Fc (carbohydrate containing) fragment of immunoglobulin G (resulting from breakdown of immunoglobulin G antibodies) in urine, serum, and other body fluids. Measurement of immunoglobulin G Fc fragments aids in the diagnosis of plasma cell antibody-forming abnormalities, e.g., gamma heavy chain disease.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 61 FR 1119, Jan. 16, 1996; 66 FR 38793, July 25, 2001]
# C_2016232EN.01001402.xml

| 27.6.2016 | EN | Official Journal of the European Union | C 232/14 |
| --- | --- | --- | --- |

27.6.2016

EN

Official Journal of the European Union

C 232/14

---

Judgment of the General Court of 12 May 2016 — Ivo-Kermartin v EUIPO — Ergo Versicherungsgruppe (ELGO)

(Case T-750/14) (1)

1

((EU trade mark - Opposition proceedings - Application for EU word mark ELGO - Earlier EU word and figurative marks ERGO - Relative ground for refusal - Article 8(1)(b) of Regulation (EC) No 207/2009 - Likelihood of confusion - Successive restrictions on the application for registration - Article 43(1) of Regulation No 207/2009 - Second sentence of Article 75 of Regulation No 207/2009 - Right to be heard - Rule 69 of Regulation No 2868/95))

(2016/C 232/18)

Language of the case: German

Parties

Parties

Applicant: Ivo-Kermartin GmbH (Walzenhausen, Switzerland) (represented by: F. Henkel, lawyer)

Applicant:

Defendant: European Union Intellectual Property Office (represented by: S. Hanne, acting as Agent)

Defendant:

Other party to the proceedings before the Board of Appeal of EUIPO: Ergo Versicherungsgruppe AG (Düsseldorf, Germany)

Other party to the proceedings before the Board of Appeal of EUIPO:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 22 August 2014 (Case R 473/2014-4) relating to opposition proceedings between Ergo Versicherungsgruppe AG and Ivo-Kermartin GmbH.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Ivo-Kermartin GmbH to bear its own costs and to pay the costs of the European Union Intellectual Property Office (EUIPO). |
| --- | --- |

2.

Orders Ivo-Kermartin GmbH to bear its own costs and to pay the costs of the European Union Intellectual Property Office (EUIPO).

---

(1)  OJ C 26, 26.1.2015.

1

---
§ 520.852 Estriol. ( a ) *Specifications.* Each tablet contains 1 milligram (mg) estriol.
( b ) *Sponsor.* See No. 000061 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* Administer at an initial dose of 2 mg per dog per day. The dosage may be titrated to as low as 0.5 mg per dog every second day, depending on response.
( 2 ) *Indications for use.* For the control of estrogen-responsive urinary incontinence in ovariohysterectomized female dogs.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[76 FR 78150, Dec. 16, 2011]
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> US DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-26-1998
<PERIOD-START>                             DEC-28-1997
<PERIOD-END>                               JUN-27-1998
<EXCHANGE-RATE>                                      1
<CASH>                                            3832
<SECURITIES>                                         0
<RECEIVABLES>                                    39900
<ALLOWANCES>                                      3456
<INVENTORY>                                      27554
<CURRENT-ASSETS>                                 69207
<PP&E>                                           63676
<DEPRECIATION>                                   22975
<TOTAL-ASSETS>                                  233774
<CURRENT-LIABILITIES>                            37433
<BONDS>                                         134314
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            80
<OTHER-SE>                                       55674
<TOTAL-LIABILITY-AND-EQUITY>                    233774
<SALES>                                         107393
<TOTAL-REVENUES>                                107393
<CGS>                                            72561
<TOTAL-COSTS>                                    21298
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                6388
<INCOME-PRETAX>                                   7253
<INCOME-TAX>                                      2978
<INCOME-CONTINUING>                               4275
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                   5107
<CHANGES>                                            0
<NET-INCOME>                                     (832)
<EPS-PRIMARY>                                   (0.10)
<EPS-DILUTED>                                   (0.10)
        

</TABLE>